Our FCM analysis revealed that LGR5+ glioma cells displayed significantly higher expression of these CSCs markers, indicating that LGR5+ glioma cells have stronger stem cell characteristics than LGR5− cells. This evidence concerns the gene LGR5 and central nervous system cancer.